Monitor CDC cancer screening programs, NIH funding and cancer research programs in annual Labor-HHS-Education appropriations bill
Monitor cancer research programs in annual NDAA and Defense Appropriations bill
Insurance coverage for screening and treatment of cancer
Insurance coverage for screening and treatment of cancer.
Duration: May 1, 2017
to
January 1, 2020
General Issues: Health Issues , Defense , Medicare/Medicaid , Insurance , Taxation/Internal Revenue Code , Budget/Appropriations , Medical/Disease Research/Clinical Labs
Spending: about $190,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS), White House Office, Natl Institutes of Health (NIH)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Molly McDonnell LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance
Chelsey Hickman CoS, Rep. Kay Granger; LA Sen. Larry Craig
Mike Merola Deputy CoS, Sen. Torricelli
Donna Mullins CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2020
WINNING STRATEGIES WASHINGTON terminated an engagement in which they represented Colorectal Cancer Coalition on March 20, 2020.
Original Filing: 301153135.xml
Lobbying Issues
Monitor CDC cancer screening programs, NIH funding and cancer research programs in annual Labor-HHS-Education appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research programs in annual NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Insurance coverage for screening and treatment of cancer
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Insurance coverage for screening and treatment of cancer.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Colorectal Cancer Coalition , earning $10,000. The report was filed on Jan. 17, 2020.
Original Filing: 301108408.xml
Lobbying Issues
Monitor CDC cancer screening programs, NIH funding and cancer research programs in annual Labor-HHS-Education appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research programs in annual NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Insurance coverage for screening and treatment of cancer
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Insurance coverage for screening and treatment of cancer.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Colorectal Cancer Coalition , earning $20,000. The report was filed on Oct. 15, 2019.
Original Filing: 301065471.xml
Lobbying Issues
Monitor CDC cancer screening programs, NIH funding and cancer research programs in annual Labor-HHS-Education appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research programs in annual NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Insurance coverage for screening and treatment of cancer
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Insurance coverage for screening and treatment of cancer.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Colorectal Cancer Coalition , earning $20,000. The report was filed on July 19, 2019.
Original Filing: 301050645.xml
Lobbying Issues
Monitor CDC cancer screening programs, NIH funding and cancer research programs in annual Labor-HHS-Education appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research programs in annual NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Insurance coverage for screening and treatment of cancer
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Insurance coverage for screening and treatment of cancer.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Colorectal Cancer Coalition , earning $20,000. The report was filed on April 16, 2019.
Original Filing: 301026463.xml
Lobbying Issues
Monitor CDC cancer screening programs, NIH funding and cancer research programs in annual Labor-HHS-Education appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research programs in annual NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Insurance coverage for screening and treatment of cancer
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Insurance coverage for screening and treatment of cancer.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Colorectal Cancer Coalition , earning $20,000. The report was filed on Jan. 17, 2019.
Original Filing: 301006114.xml
Lobbying Issues
Monitor CDC cancer screening programs; NIH funding and cancer research programs in FY 2019 Labor-HHS-Education appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research programs in FY 2019 NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
insurance coverage for screening and treatment of cancer
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
insurance coverage for screening and treatment of cancer
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Colorectal Cancer Coalition , earning $20,000. The report was filed on Oct. 19, 2018.
Original Filing: 300991630.xml
Lobbying Issues
Monitor CDC cancer screening programs; NIH funding and cancer research programs in FY 2019 Labor-HHS-Education appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research programs in FY 2019 NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
insurance coverage for screening and treatment of cancer
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
insurance coverage for screening and treatment of cancer
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Colorectal Cancer Coalition , earning $20,000. The report was filed on July 19, 2018.
Original Filing: 300969521.xml
Lobbying Issues
Monitor CDC cancer screening programs; NIH funding and cancer research programs in FY 2018 and FY 2019 Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer research programs in FY2018 and FY 2019 NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
insurance coverage for screening and treatment of cancer
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
insurance coverage for screening and treatment of cancer
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, WINNING STRATEGIES WASHINGTON lobbied for Colorectal Cancer Coalition , earning $20,000. The report was filed on April 18, 2018.
Original Filing: 300947092.xml
Lobbying Issues
Monitor CDC cancer screening programs; NIH funding and cancer research programs within DOD in FY 2018 and FY 2019 Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer screening programs in FY2018 and FY 2019 NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1017 Removing Barriers to Colorectal Cancer Screening Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1409 Cancer Drug Coverage Parity Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, WINNING STRATEGIES WASHINGTON lobbied for Colorectal Cancer Coalition , earning $10,000. The report was filed on Jan. 17, 2018.
Original Filing: 300925190.xml
Lobbying Issues
Monitor Hatch Brady and the Bipartisan Health Care Stabilization Act of 2017
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer screening programs in FY2018 NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1017 Removing Barriers to Colorectal Cancer Screening Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
monitor tax reform provisions including the repeal of the ACA individual mandate, medical expenses deduction, the charitable deduction, and the orphan drug tax credit.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, WINNING STRATEGIES WASHINGTON lobbied for Colorectal Cancer Coalition , earning $10,000. The report was filed on Oct. 16, 2017.
Original Filing: 300904584.xml
Lobbying Issues
Monitor the Graham Cassidy Substitute Amendment; monitor CDC cancer screening programs in FY2018 Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer screening programs in FY2018 NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1017 Removing Barriers to Colorectal Cancer Screening Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2017
In Q2, WINNING STRATEGIES WASHINGTON lobbied for Colorectal Cancer Coalition , earning $10,000. The report was filed on July 18, 2017.
Original Filing: 300886958.xml
Lobbying Issues
The Better Care Reconciliation Act draft substitute amendment and H.R. 1628, American Health Care Act; monitor CDC cancer screening programs in FY2018 Labor-HHS-Education appropriations bills
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor cancer screening programs in FY2018 NDAA and Defense Appropriations bill
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1017 Removing Barriers to Colorectal Cancer Screening Act
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2017
WINNING STRATEGIES WASHINGTON filed a lobbying registration on May 24, 2017 to represent Colorectal Cancer Coalition, effective May 1, 2017.
Original Filing: 300880519.xml
Issue(s) they said they’d lobby about: Monitoring cancer related legislation, research funding, and CMS reimbursement policies. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...